Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Daily fermented whey consumption alters fasting insulin levels and the faecal short-chain fatty acid profile in healthy adults

ABSTRACT: Investigation on the impact of Molkosan, a fermented whey rich in lactic acid, on insulin levels, short-chain fatty acid profiles, and the gut microbiota of healthy adults.

PROVIDER: PRJEB30495 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Daily Fermented Whey Consumption Alters the Fecal Short-Chain Fatty Acid Profile in Healthy Adults.

Project description:Gut microbiota influences many aspects of host health including immune, metabolic, and gut health. We examined the effect of a fermented whey concentrate (FWC) drink rich in L-(+)-Lactic acid, consumed daily, in 18 healthy men (n = 5) and women (n = 13) in free-living conditions. Objective: The aims of this 6-weeks pilot trial were to (i) identify changes in the gut microbiota composition and fecal short chain fatty acid (SCFA) profile, and (ii) to monitor changes in glucose homeostasis. Results: Total fecal SCFA (mM) concentration remained constant throughout the intervention. Proportionally, there was a significant change in the composition of different SCFAs compared to baseline. Acetate levels were significantly reduced (-6.5%; p < 0.01), coupled to a significant increase in the relative amounts of propionate (+2.2%; p < 0.01) and butyrate (+4.2%; p < 0.01), respectively. No changes in the relative abundance of any specific bacteria were detected. No significant changes were observed in glucose homeostasis in response to an oral glucose tolerance test. Conclusion: Daily consumption of a fermented whey product led to significant changes in fecal SCFA metabolite profile, indicating some potential prebiotic activity. These changes did not result in any detectable differences in microbiota composition. Post-hoc analysis indicated that baseline microbiota composition might be indicative of participants likely to see changes in SCFA levels. However, due to the lack of a control group these findings would need to be verified in a rigorously controlled trial. Future work is also required to identify the biological mechanisms underlying the observed changes in microbiota activity and to explore if these processes can be harnessed to favorably impact host health. Clinical Trial Registration: www.clinicaltrials.gov, identifier NCT03615339; retrospectively registered on 03/08/2018.

| S-EPMC7556162 | biostudies-literature

Cheese whey

Project description:Cheese whey Metagenome (DC4)

| PRJNA497528 | ENA

Cheese whey

Project description:Cheese whey Metagenome (DC2)

| PRJNA497526 | ENA

Cheese whey

Project description:Cheese whey Metagenome (DC1)

| PRJNA529354 | ENA

Cheese whey (DC3)

Project description:Cheese whey Metagenome (DC3)

| PRJNA529357 | ENA

acid whey reactor study

Project description:Temperature-phased conversion of acid whey waste into medium-chain carboxylic acids via lactic acid: no external e-donor.

| PRJEB21186 | ENA

Whey Protein-based Enteral Nutrition Support to Improve Protein Economy in Surgical Patients

Project description:A prospective, randomized and controlled study is proposed to establish whether an enteral nutrition support regimen based on pressurized whey protein and glucose improves the postoperative utilization of amino acid substrates compared to a drink based on glucose alone. The kinetics of protein metabolism (protein breakdown, protein synthesis and amino acid oxidation) will be investigated using stable isotope methodology before and after surgery in patients undergoing colon resection. Stable isotope infusions will be conducted one week before surgery and on the second postoperative day for two hours in the fasted state and for four hours while sipping the enteral nutrition support regimen. Patients will consume one of two enteral nutrition support regimens consisting of a drink containing either pressurized whey protein and glucose or glucose alone. It is hypothesized that an enteral nutrition support regimen based on pressurized whey protein and glucose promotes positive protein balance through increased protein synthesis or reduced protein breakdown compared to glucose alone.

| 2100821 | ecrin-mdr-crc

Postprandial effects of protein from salmon by-products and whey on gene expression in liver cells.

Project description:Exploring the metabolic effects of fish protein is important, as by-products from fish contain large amounts of proteins that could be used for human consumption. The aim of this study was to investigate the postprandial effects of intake of protein from salmon by-products, compared to whey. As part of this effort, the effects on gene expression in liver cells were studied in vitro. This was done by incubating HepG2 cells with human serum taken before (fasting) or 30 and 60 min after intake of salmon protein or whey and comparing that with HepG2 cells incubated in serum-free medium. Transcriptomic profiling of the cells was done with RNA sequencing.

2022-04-12 | GSE178584 | GEO

Randomized trial of whey protein to prevent colorectal neoplasia

Project description:Interventions: Whey protein Placebo Primary outcome(s): After taking whey protein for 1 year, the prevention of colorectal neoplasia will be examined with colonoscopy. Study Design: Parallel Randomized

| 2647867 | ecrin-mdr-crc